National Pension Service Bei Gene, Ltd. Transaction History

National Pension Service

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Feb 23, 2023	BUY	$131.8 - $202.24 $1.25 Million - $1.91 Million	9,456 New	9,456 $1.27 Million
Q3 2022 Nov 17, 2022	SELL	$131.8 - $202.24 $95,686 - $146,826	-726 Reduced 7.13%	9,456 $1.29 Million
Q2 2022 Aug 17, 2022	BUY	$121.11 - $216.05 $1.13 Million - $2.02 Million	9,333 Added 1099.29%	10,182 $1.65 Million
Q4 2021 Feb 15, 2022	BUY	$248.56 - $389.34 $211,027 - $330,549	849 New	849 $230,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

Stay updated on National Pension Service with notifications on news.